We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Rapid Method for Determining Virus Infectivity Could Revolutionize Response to Future Pandemics

By LabMedica International staff writers
Posted on 25 Jul 2024
Print article
Image: The researchers selected a molecule that cannot penetrate a viral capsid and conjugated it to a dye that can (Photo courtesy of Dr Samuel Jones, University of Birmingham)
Image: The researchers selected a molecule that cannot penetrate a viral capsid and conjugated it to a dye that can (Photo courtesy of Dr Samuel Jones, University of Birmingham)

On average, every four years a new virus emerges that poses a pandemic threat, in addition to numerous already known viruses that have the potential to jump across species. Currently, there is no test that can quickly determine whether a virus in a sample is intact and potentially infectious, or damaged and non-infectious, without requiring weeks of cell culture. The traditional method for assessing viral infectivity involves the use of cultured cells, which not only takes days to yield results but also requires specialized personnel and specific cell lines that are not always available for every virus. Additionally, this method is limited to evaluating antivirals that do not harm the cells, complicating the discovery of new disinfectants that can interrupt the chain of viral transmission. Now, a new groundbreaking assay can screen viruses against virucidal antivirals in minutes, enabling quick determination of the effectiveness of antiviral measures, such as disinfectants.

This innovative technique, devised by researchers at the University of Birmingham’s School of Chemistry (Birmingham, UK), has been described in a study published in ACS Biomacromolecules. It employs a dye that can ordinarily penetrate viruses through pores in the capsid (protein shell) that surrounds its genetic material (DNA or RNA). When the dye binds to the viral DNA or RNA, it emits a fluorescent signal. The resulting assay, named FAIRY (Fluorescence Assay for vIRal IntegritY), quickly indicates whether a virus is intact and likely infectious, or damaged and non-infectious. The effectiveness of the FAIRY assay was tested on various viruses, including herpes simplex virus (HSV-2), respiratory syncytial virus (RSV), cytomegalovirus (CMV), Human Rhinovirus-8 (HRV-8), Human Coronavirus OC43 (OC43), chikungunya virus (CHIKV), Dengue virus 1 and 2, zika virus, and enterovirus 71 (EV71).

The FAIRY assay’s broad applicability was demonstrated across both enveloped and non-enveloped viruses, and DNA and RNA viruses. These viruses were subjected to treatments with a variety of chemicals known for their virucidal properties, such as hydrogen peroxide, ethanol, isopropanol, and other antivirals. The tests confirmed that the FAIRY assay is a promising tool for the rapid evaluation of virucides that disrupt viral capsids.

“This simple, low-cost, assay uses ready-made consumables, and can rapidly screen multiple disinfectants and viruses, in a single microplate assay, for their ability to neutralize viral infectivity,” said Dr. Samuel Jones from Birmingham’s School of Chemistry led the research team that developed the FAIRY assay. “It could have screened every disinfectant for antiviral activity during the SARS-CoV-2 pandemic and so deliver a more rapid response during the next pandemic.”

Related Links:
University of Birmingham’s School of Chemistry

New
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Slit Lamp Micro
KJ5X
New
EBV DNA Quantitative Fluorescence Diagnostic Kit
S3015E EBV

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The LIAISON PLEX Gram-Negative Blood Culture Assay runs on the on the LIAISON PLEX instrument (Photo courtesy of Diasorin)

Molecular Multiplexing Panel for Blood Culture Identification Enables Targeted Treatment Decisions

Each year, approximately 250,000 patients in the US are diagnosed with bloodstream infections (BSIs). Sepsis resulting from BSIs has an average mortality rate of 16-40%, and any delays in initiating appropriate... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: International expert meeting for trends and innovations in laboratory medicine - the MEDICA LABMED FORUM at MEDICA (Photo courtesy of Constanze Tillmann/Messe Düsseldorf)

MEDICA LABMED FORUM 2024: International Experts Meet to Discuss Trending Topics in Laboratory Medicine

At MEDICA (Düsseldorf, Germany), the world’s premier trade fair for the healthcare industry and medical technology sector, this year’s event (November 11–14) will focus on the most exciting medical advancements.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.